Related Experiment Video
Updated: Mar 24, 2026
07:31
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
4.4K
A porcine model of osteosarcoma
A Saalfrank1, K-P Janssen2, M Ravon3
1Chair of Livestock Biotechnology, Technische Universität München, Freising, Germany.
Oncogenesis
|March 15, 2016
Summary
Researchers created pigs with a mutated tumor suppressor gene (TP53) to study cancer. These pigs developed osteosarcomas, offering a new model for human sarcoma research.
Area of Science:
- Oncology
- Genetics
- Comparative Pathology
Background:
- Germline TP53 mutations predispose humans to various cancers, including sarcomas.
- Loss of p53 function is implicated in over 50% of human cancers.
- A porcine model for human sarcoma research is needed.
Purpose of the Study:
- To develop a porcine model for human sarcomagenesis.
- To investigate the role of engineered TP53 mutations in cancer development.
- To establish a model for juvenile osteosarcoma.
Main Methods:
- Engineered latent oncogenic TP53 and KRAS mutations in porcine mesenchymal stem cells (MSCs).
- Overexpressed MYC to promote tumorigenesis.
- Transplanted transformed MSCs into immune-deficient mice.
- Generated heterozygous and homozygous TP53 knockout pigs.
Main Results:
- Activated TP53 and KRAS mutations, along with MYC overexpression, transformed porcine MSCs.
- Transformed MSCs exhibited genomic instability and formed sarcomas in mice.
- TP53 knockout pigs developed spontaneous osteosarcomas, with homozygous knockouts showing multiple tumors.
- Tumor development in pigs closely mimicked human osteosarcoma in long bones and skull.
Conclusions:
- Engineered TP53 mutations in pigs lead to invasive cancer, establishing a novel model.
- This porcine model closely recapitulates human osteosarcoma, including juvenile forms.
- The study provides a valuable platform for studying sarcoma development and testing therapies.
